I had the honour and responsibility of leading the strategic rebrand of the 40-year-old Australasian Gastro-Intestinal Trials Group and GI Cancer Institute into GI Cancer Trials, creating a unified identity that clarified purpose, strengthened public recognition, and aligned clinical, donor, and community communications under one cohesive brand. The project balanced scientific credibility with a human-centred visual approach, evolving existing brand equity into a contemporary identity designed to support engagement, trust, and innovation in GI cancer research.